Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Not for use in food, drug, or cosmetic applications
Mechanism: AOD 9604 stimulates lipolysis and inhibits lipogenesis in fat cells via beta-3 adrenergic receptors
Save your consults
This molecule can also inhibit the activity of carbamoyl phosphate synthetase I, an enzyme of the urea cycle that normally metabolizes ammonia to carbamoyl phosphate
Our BPC-157 is manufactured under strict quality-control standards, and we supply it with supporting quality documentation
AOD-9604 was developed to: Stimulate lipolysis (breakdown of stored fat) Inhibit lipogenesis (formation of new fat) Avoid raising IGF-1 levels Reduce impact on blood glucose Because it is a small fragment rather than the full hormone, it theoretically targets fat metabolism more specifically
US$ 20.58
US$ 23.25
US$ 21.42
US$ 24.70
US$ 25.84
US$ 24.72
US$ 29.14
